Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Surgery Today
Published in: Surgery Today 2/2015

01-02-2015 | Review Article

The history of lymphadenectomy for esophageal cancer and the future prospects for esophageal cancer surgery

Author: Hiromasa Fujita

Published in: Surgery Today | Issue 2/2015

Login to get access

Abstract

I would herein like to look back upon surgery for esophageal cancer, particularly on lymphadenectomy, and to speculate a little on the future prospects for esophageal surgery. There are two schools of thought on lymphadenectomy in esophageal cancer: one believes in en bloc esophagectomy, which is commonly performed in Western countries; the other believes in three-field lymphadenectomy, which is commonly performed in Japan. We esophageal surgeons at Kurume University have contributed to some advances in three-field lymphadenectomy. For example, we initiated functional mediastinal dissection to ensure patient safety, and we proposed the lymph node compartment theory to assess the clinical importance of regional nodes. Oncological surgery has progressed in terms of its safety, radicality and functional preservation, leading to improved quality-of-life for patients after surgery. This then evolved to the current development of multimodal and individualized tailor-made treatments. I believe that surgery for esophageal cancer will become bipolarized in the future. One strand will evolve as salvage surgery for residual or recurrent tumors, which non-surgical therapies have failed to cure, and the other strand will evolve as less invasive surgery, adjuvant surgery, for cancers at the relatively early stage, for which micro-metastasis can be cured by non-surgical therapies.
Literature
1.
Scannel JG. Historical perspectives Samuel J. Meltzer (1851–1920). J Thorac Cardiovasc Surg. 1996;111:905–6.CrossRef
2.
Torek F. The first successful case of resection of the thoracic portion of the oesophagus for carcinoma. Surg Gynecol Obstet. 1913;16:614–7.
3.
Lewis I. The surgical treatment of carcinoma of the oesophagus with special reference to a new operation for growths of the middle third. Br J Surg. 1946;34:18–31.PubMedCrossRef
4.
Logan A. The surgical treatment of carcinoma of the esophagus and cardia. J Thorac Cardiovasc Surg. 1963;46:150–61.PubMed
5.
Skinner DB. En bloc resection for neoplasms of the esophagus and cardia. J Thorac Cardiovasc Surg. 1983;85:59–71.PubMed
6.
Siewert JR, Hölscher AH. Eingriffe beim Ösophaguskarzinom. In: Siewert JR, editor. Breitner Chirurgische Operationslehre Band IV, Chirurgie des Abdomens 2 Ösophagus, Magen und Duodenum. Baltimore: Urban & Schwarzenberg; 1989. p. 17–54.
7.
Orringer MB. Technical aids in performing transhiatal esophagectomy without thoracotomy. Ann Thorac Surg. 1984;38:128–32.PubMedCrossRef
8.
Nakayama K, Yanagisawa F, Nabeya K, Tomita T, Kobayashi S, Makino K. Concentrated preoperative irradiation therapy. Arch Surg. 1963;87:1003–18.CrossRef
9.
Katsura S. Surgical indication of esophageal cancer, prognosis after surgery, and postoperative complaints and their treatments (in Japanese. Nippon Kyobu Geka Gakkai Zasshi (Jpn J Thorac Cardiovasc Surg). 1957;6:600–5.
10.
Akakura I, Nakamura Y, Kakegawa T, Nakayama R, Watanabe H, Yamashita H. Surgery of carcinoma of the esophagus with preoperative radiation. Chest. 1970;57:47–57.PubMedCrossRef
11.
Seo S. Esophageal surgery (in Japanese). Nippon Geka Gakkai Zasshi (J Jpn Surg Assoc). 1933;33:1461–505.
12.
Osawa T. Esophageal surgery (in Japanese). Nippon Geka Gakkai Zasshi (J Jpn Surg Assoc). 1933;34:1319–590.
13.
Kinoshita I, Ohashi I, Nakagawa K, Kajitani T, Kaneda K, Tsuya A. Lymph node metastasis in esophageal cancer; with special reference to upper mediastinum and measures for its treatment (in Japanese). Nippon Syokaki Geka Gakkai Zasshi (Jpn J Gastroenetrol Surg). 1976;9:424–30.CrossRef
14.
Sannohe Y, Hiratsuka R, Doki K. Lymph node metastases in cancer of the thoracic esophagus. Am J Surg. 1981;141:216–8.PubMedCrossRef
15.
Kakegawa T, Yamana H, Fujita H. Cervical lymph node dissection during radical esophagectomy (in Japanese). Geka Shinryo (Surg Diagn Treat). 1986;28:523–8.
16.
Isono K, Onoda S, Okuyama K, Tohnosu N. The significance of cervical lymph nodes dissection in radical operation of esophageal cancer (in Japanese). Geka Shinryo (Surg Diagn Treat). 1986;28:529–35.
17.
Muto T, Hasegawa M, Katayanagi N, Sasaki K, Tanaka O. Appraisal of cervical lymph node dissection for thoracic esophageal carcinoma (in Japanese). Geka Shinryo (Surg Diagn Treat). 1986;28:536–40.
18.
Tsurumaru M, Akiyama H, Ono Y, Watanabe G, Udagawa H, Suzuki M. The significance of cervical lymph nodes dissection in radical operation of esophageal cancer (in Japanese). Geka Shinryo (Surg Diagn Treat). 1986;28:555–60.
19.
Japanese Society for Esophageal Diseases. Esophageal cancer—descriptive rules in clinic and pathology (in Japanese). 1st edn. In: Sato H, editor. Tokyo: Japanese Society for Esophageal Diseases; 1969.
20.
International Union Against Cancer. TNM classification of malignant tumours. 1st edn. In: Committee on TNM Classification, editor. Geneva: International Union Against Cancer; 1968.
21.
International Union Against Cancer. TNM classification of malignant tumours. 7th edn. In: Sobin LH, Gospodarowicz MK, Wittekind Ch, editors. New York: Wiley-Blackwell; 2009.
22.
Japanese Research Society for Gastric Cancer. General rules for the gastric cancer in study and pathology (in Japanese). 4th edn. In: Jinnai D, Kajitani T, Kuru M, Maki T, Murakami T, Muto M, Nakayama K, Sakai T, editors. Tokyo: Kanehara; 1965.
23.
Fujita H. The mode of recurrence of esophageal cancer after surgical treatment—autopsy study. Nippon Geka Gakkai Zasshi (J Jpn Surg Assoc). 1984;85:17–28.
24.
Mitomi T, Makuuchi H, Machimura T, Sugihara T, Sou Y, Sasaki T. Surgery for cancer of the thoracic esophagus: cervical and upper mediastinal lymphadenectomy through an upper median sternotomy (in Japanese). Shujutsu (Oper). 1989;43:1525–31.
25.
Mori S, Kitamura M, Nishihira T. Resection and reconstruction of the thoracic esophagus with special reference to extended lymphadenectomy for the neck and upper mediastinum and esophageal reconstruction (in Japanese). Shujutsu (Oper). 1990;44:53–60.
26.
Akiyama H. Surgery for cancer of the esophagus. Baltimore: Williams & Wilkins; 1990.
27.
Fujita H, Kawahara H, Hidaka M, Nagano T, Yoshimatsu H. An experimental study on viability of the devascularized trachea. Jpn J Surg. 1988;18:77–83.PubMedCrossRef
28.
Fujita H, Kawahara H, Yamana H, Shirouzu G, Yoshimura Y, Minami T, Negoto Y, Irie H, Shima T, Machi J, Kakegawa T. Mediastinal lymphnode dissection procedure during esophageal cancer operation—carefully considered for preserving respiratory function. Jpn J Surg. 1988;18:31–4.PubMedCrossRef
29.
Fujita H, Sueyoshi S, Fujii T, Toh U, Tanaka T, Mine T, Sasahara H, Matono H, Shirouzu K. Functional three-field dissection for esophageal cancer. In: Pinotti HW, Cecconello I, Felix VN, de Oliveira MA, editors. Recent advances in diseases of the esophagus. Bologna: Monduzzi Editore; 2001. p. 525–31.
30.
Cuschieri A, Shimi S, Banting S. Endoscopic oesophagectomy through a right thoracoscopic approach. J R Coll Surg Edinb. 1992;37:7–11.PubMed
31.
Akaishi T, Kaneda I, Higuchi N, Kuriya Y, Kuramoto J, Toyoda T, Wakabayashi A. Thoracoscopic en bloc total esophagectomy with radical mediastinal lymphadenectomy. J Thorac Cardiovasc Surg. 1996;112:1533–41.PubMedCrossRef
32.
Ohsugi H. Radical operation for cancer in the thoracic esophagus, video-assisted thoracoscopic surgery (VATS). Syujutsu (Oper). 2009;63:713–20.
33.
Bodner J, Wykypiel H, Wetscher G, Schmid T. First experiences with the da Vinci™ operating robot in thoracic surgery. Eur J Cardiothorac Surg. 2004;25:844–51.PubMedCrossRef
34.
Suda K, Ishida Y, Kawamura Y, Inaba K, Kanaya S, Teramukai S, Satoh S, Uyama I. Robot-assisted thoracoscopic lymphadenectomy along the left recurrent laryngeal nerve for esophageal squamous cell carcinoma in the prone position: technical report and short-term outcomes. World J Surg. 2012;36:1608–16.PubMedCrossRef
35.
Isono K, Sato H, Nakayama K. Results of a nationwide study on the three-field lymph node dissection of esophageal cancer. Oncology. 1991;48:411–20.PubMedCrossRef
36.
Kato H, Watanabe H, Tachimori Y, Iizuka T. Evaluation of neck lymph node dissection for thoracic esophageal carcinoma. Ann Thorac Surg. 1991;51:931–5.PubMedCrossRef
37.
Fujita H, Kakegawa T, Yamana H, Hoelscher AH, Bollschweiler E, Siewert JR. The results of en bloc esophagectomy compared with three-field and two-field dissection. In: Nabeya K, Hanaoka T, Nogami H, editors. Recent advances in diseases of the esophagus. Tokyo: Springer; 1993. p. 703–8.CrossRef
38.
39.
Fujita H, Kakegawa T, Yamana H, Shima I, Toh U, Tomita Y, Fujii T, Yamasaki K, Higaki K, Noake T, Ishibashi N, Mizutani K. Mortality and morbidity rates, postoperative course, quality of life, and prognosis after extended radical lymphadenectomy for esophageal cancer; comparison of three-field lymphadenectomy with two-field lymphadenectomy. Ann Surg. 1995;222:654–62.PubMedCentralPubMedCrossRef
40.
Kakegawa T, Fujita H, Yamana H. Esophageal cancer: lymphadenectomy based on the lymph node compartment classification. Dig Surg. 1993;10:148–54.CrossRef
41.
Fujita H, Kakegawa T, Yamana H, Shima I. Lymph node compartments as guidelines for lymphadenectomy for esophageal carcinoma. Dis Esophagus. 1994;7:169–78.
42.
Japanese Society for Esophageal Diseases. Guide lines for clinical and pathologic studies on carcinoma of the esophagus (in Japanese), 9th English edn. In: Tsurumaru H, Ando N, Fumani Y, Ikeda H, Kato H, Matsubara T, Tachimori Y, Kabuto K, Yoshida M, editors. Tokyo: Kanehara; 2001.
43.
Fujita H. History of the Japanese classification of esophageal cancer. Esophagus. 2011;8:233–45.CrossRef
44.
Yada I, Wada H, Fujita H. Thoracic and cardiovascular surgery in Japan during 2002, annual report by the Japanese Association for Thoracic Surgery. Jpn J Thorac Cardiovasc Surg. 2004;52:491–508.CrossRef
45.
46.
Fujita H, Kakegawa T, Yamana H, Shima I, Tanaka H, Ikeda S, Nogami S, Toh Y. Lymph node metastasis and recurrence in patients with a carcinoma of the thoracic esophagus who underwent three-field dissection. World J Surg. 1994;18:266–72.PubMedCrossRef
47.
Amano J, Kuwano H, Yokomise H. Thoracic and cardiovascular surgery in Japan during 2011: annual report by the Japanese Association for Thoracic Surgery. Gen Thorac Cardiovasc Surg. 2013;61:578–607.PubMedCrossRef
48.
Ando N, Kato H, Igaki H, Shinoda M, Ozawa S, Shimizu H, Nakamura T, Yabusaki H, Aoyama N, Kurita A, Ikeda K, Kanda T, Tsujinaka T, Nakamura K, Fukuda H. A randomized trial comparing postoperative adjuvant chemotherapy with cisplatin and 5-fluorouracil versus preoperative chemotherapy for localized advanced squamous cell carcinoma of the thoracic esophagus (JCOG9907). Ann Surg Oncol. 2012;19:68–74.PubMedCrossRef
49.
van Hagen P, Hulshof MC, van Lanschot JJ, Steyerberg EW, van Berg Henegouwen MI, Wijnhoven BP, Richel DJ, Nieuwenhuijzen GA, Hospers GA, Bonenkamp JJ, Cuesta MA, Blaisse RJ, Busch OR, ten Kate FJ, Creemers GJ, Punt CJ, Plukker JT, Verheul HM, Spillenaar Bilgen EJ, van Dekken H, van der Sangen MJ, Rozema T, Biermann K, Beukema JC, Piet AH, van Rij CM, Reinders JG, Tilanus HW, van der Gaast A, CROSS Group. Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med. 2012;366:2074–84.
50.
Hironaka S, Ohtsu A, Boku N, Muto M, Nagashima F, Saito H, Yoshida S, Nishimura M, Haruno M, Ishikura S, Ogino T, Yamamoto S, Ochiai A. Nonrandomized comparison between definitive chemoradiotherapy and radical surgery in patients with T2-3NanyM0 squamous cell carcinoma of the esophagus. Int J Radiat Oncol Biol Phys. 2003;57:425–33.PubMedCrossRef
51.
Swisher SG, Wynn P, Putnam JB, Mosheim MB, Correa AM, Komaki RR, Ajani JA, Smythe WR, Vaporciyan AA, Roth JA, Walsh GL. Salvage esophagectomy for recurrent tumors after definitive chemotherapy and radiotherapy. J Thorac Cardiovasc Surg. 2002;123:175–83.PubMedCrossRef
52.
Ariga H, Nemoto K, Miyazaki S, Yoshioka T, Ogawa Y, Sakayauchi T, Jingu K, Miyata G, Onodera K, Ishikawa H, Kamei T, Kato S, Ishioka C, Satomi S, Yamada S. Prospective comparison of surgery alone and chemoradiotherapy with selective surgery in resectable squamous cell carcinoma of the esophagus. Int J Radiat Oncol Biol Phys. 2009;75:348–56.PubMedCrossRef
53.
Tachimori Y. Salvage surgery after chemoradiotherapy for the esophageal carcinoma (in Japanese). Rinsyo Geka (J Clin Surg). 2005;60:193–9.
54.
Stahl M, Stuschke M, Lehmann N, Meyer HJ, Walz MK, Seeber S, Klump B, Budach W, Teichmann R, Schmitt M, Schmitt G, Franke C, Wilke H. Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus. J Clin Oncol. 2005;23:2310–7.PubMedCrossRef
55.
Bedenne L, Michel P, Bouche O, Milan C, Mariette C, Conroy T, Pezet D, Roullet B, Seitz JF, Herr JP, Paillot B, Arveux P, Bonnetain F, Binquet C. Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD9102. J Clin Oncol. 2007;25:1160–8.PubMedCrossRef
56.
57.
58.
59.
Fisher B. Laboratory and clinical research in breast cancer—a personal adventure: the David A. Karnofsky Memorial Lecture. Cancer Res. 1980;40:3863–74.PubMed
60.
Fisher B. From Halsted to prevention and beyond: advances in the management of breast cancer during the twentieth century. Eur J Cancer. 1999;35:1963–73.PubMedCrossRef
61.
Hellman S. Natural history of small breast cancers. J Clin Oncol. 1994;12:2229–34.PubMed
Metadata
Title
The history of lymphadenectomy for esophageal cancer and the future prospects for esophageal cancer surgery
Author
Hiromasa Fujita
Publication date
01-02-2015
Publisher
Springer Japan
Published in
Surgery Today / Issue 2/2015
Print ISSN: 0941-1291
Electronic ISSN: 1436-2813
DOI
https://doi.org/10.1007/s00595-014-0841-4

Other articles of this Issue 2/2015

Surgery Today 2/2015 Go to the issue

How to Do It

A novel laparoscopic approach for severe esophageal stenosis due to reflux esophagitis: how to do it

Original Article

The soluble VEGFR1 concentration in the serum of patients with colorectal cancer

Original Article

Role of surgery in multi-modality treatment for carcinomatous pleuritis in patients with non-small cell lung cancer

Case Report

Chemotherapy for anaplastic thyroid cancer using docetaxel and cisplatin: report of eight cases

Original Article

Endovascular treatment for unilateral chronic total occlusions of the iliac artery categorized as TASC II type D lesions

Case Report

Our experience of treating undifferentiated gastric carcinoma: report of four cases